Turner syndrome: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• DMD 0

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 67 institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Withdrawn

  Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnancy: A Deep Phenotype Study

  NCT05548881· Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)· Updated 2 Apr 2025

  “Study closed due to lack of resources. Study had no recruitment.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

  NCT05723835· Novo Nordisk A/S· Source

• A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow

  NCT05330325· Novo Nordisk A/S· Source

• A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRIFECTA-DARED Approach for Rare Diseases

  NCT07041814· Universiti Kebangsaan Malaysia Medical Centre· Source

• UTHealth Turner Syndrome Research Registry

  NCT03185702· The University of Texas Health Science Center, Houston· Source

• Growing up With the Young Endocrine Support System (YESS!)

  NCT04252001· dr. Laura C. G. de Graaff-Herder· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Exome Sequencing 5
• Immunohistochemistry 1
• Magnetic Resonance Imaging 6
• Deep Learning 1
• Cohort Studies 5

• Thyroid Myofibroma in a Child With Turner Syndrome: Integrated Cytologic, Histopathologic, and Molecular Characterization.

  Pediatr Dev Pathol, May 2026

See which targets of this disease your abstract mentions, and go to the people working on them.